Protease-free ChABC (chondroitinase and ChABC used interchangeably; Amsbio, Seikagaku, Japan) or penicillinase (p; Spectrum, TCI, USA) as a control enzyme (with no known substrate in the brain) was dissolved in 0.1% BSA to 50 U/mL of concentration and filtered through a 0.2-micron filter [71]. In these experiments, 8-week-old animals (n = 5 males and females each) were used. Four injections in the PFC (2 per hemisphere, 0.25 μL with a speed of 0.2 μL/min) were performed stereotaxically under xylazine-ketamine injectable anesthesia (at 30 mg/kg) with a 10 μL Hamilton syringe and a 33 gauge needle at the following sites (in mm from bregma): anterior-posterior (AP): +2.68 mm; lateral (ML): ±1 mm; ventral (V): −2 mm and −1 mm. The needle remained in place at the injection site for 3 min between injections and an additional 3 min before being slowly withdrawn over a 2-min period. An n = 6 was used for each group (with 3 males and 3 females). Animals were returned to their home cages and were observed for a week before behavioral testing.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.